Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Schellenberg

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Immunology|November 9, 2002
Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathwaysXueyan Zheng, Aly Karsan, Vincent Duronio, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1999
Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF releaseD A Knight, C P Lydell, D Zhou, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|March 15, 2006
Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case reportAlon D Altman, Janice McLaughlin, Robert Schellenberg, et al.
Canadian Respiratory Journal|June 27, 2009
Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)Paul K Keith, Caroline Koch, Michel Djandji, et al.
Annals of Emergency Medicine|November 19, 2013
Incidence of clinically important biphasic reactions in emergency department patients with allergic reactions or anaphylaxisBrian E Grunau, Jennifer Li, Tae Won Yi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epitheliumStephen Lam, Jean C leRiche, Annette McWilliams, et al.
Transfusion Medicine Reviews|December 8, 2009
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guidelineNadine Shehata, Valerie Palda, Tom Bowen, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 17, 2024
Inborn errors of immunity in adulthoodJoanne J F Wang, Arün Dhir, Kyla J Hildebrand, et al.
Annals of Emergency Medicine|March 31, 2015
Emergency Department Corticosteroid Use for Allergy or Anaphylaxis Is Not Associated With Decreased RelapsesBrian E Grunau, Matthew O Wiens, Brian H Rowe, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 12, 2011
Canadian clinical practice guidelines for acute and chronic rhinosinusitisMartin Desrosiers, Gerald A Evans, Paul K Keith, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Immunology|November 9, 2002
Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathwaysXueyan Zheng, Aly Karsan, Vincent Duronio, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1999
Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF releaseD A Knight, C P Lydell, D Zhou, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|March 15, 2006
Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case reportAlon D Altman, Janice McLaughlin, Robert Schellenberg, et al.
Canadian Respiratory Journal|June 27, 2009
Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)Paul K Keith, Caroline Koch, Michel Djandji, et al.
Annals of Emergency Medicine|November 19, 2013
Incidence of clinically important biphasic reactions in emergency department patients with allergic reactions or anaphylaxisBrian E Grunau, Jennifer Li, Tae Won Yi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epitheliumStephen Lam, Jean C leRiche, Annette McWilliams, et al.
Transfusion Medicine Reviews|December 8, 2009
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guidelineNadine Shehata, Valerie Palda, Tom Bowen, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 17, 2024
Inborn errors of immunity in adulthoodJoanne J F Wang, Arün Dhir, Kyla J Hildebrand, et al.
Annals of Emergency Medicine|March 31, 2015
Emergency Department Corticosteroid Use for Allergy or Anaphylaxis Is Not Associated With Decreased RelapsesBrian E Grunau, Matthew O Wiens, Brian H Rowe, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 12, 2011
Canadian clinical practice guidelines for acute and chronic rhinosinusitisMartin Desrosiers, Gerald A Evans, Paul K Keith, et al.
Pageof 3